Position in ELAN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$11,245,089
+$44,914 QoQ
Shares Held
469,916
-5.1% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $70,326,489 across 14 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
229,939 | $11,885,546 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
469,916 | $11,245,089 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
157,126 | $9,312,858 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
272,786 | $9,021,033 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
406,175 | $7,956,968 | |
| 6 | ESPR |
Esperion Therapeutics, Inc.
|
2,626,995 | $7,197,966 | |
| 7 | SIGA |
Siga Technologies Inc
|
667,646 | $3,571,906 | |
| 8 | TKNO |
Alpha Teknova, Inc.
|
1,069,162 | $3,089,878 |
All Filings in ELAN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,245,089 | 469,916 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,200,175 | 494,926 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $12,135,638 | 602,564 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,096,188 | 496,932 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||